DELIA , Mario

Last name: DELIA

First name: Mario

2024 (v1)

Publication

Metadata-only

Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group

Forghieri, Fabio Cordella, Stefano Marchesi, Francesco

No description

Uploaded on: October 26, 2024
2023 (v1)

Publication

Metadata-only

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience

Fianchi, Luana Guolo, Fabio Marchesi, Francesco

Simple Summary CPX-351 has been approved for the treatment of adults with therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). The aim of this retrospective study was to evaluate the absolute infectious risk in a real-life setting of 200 AML patients treated with this drug. A total of 249 febrile events were...

Uploaded on: October 25, 2024
2018 (v1)

Publication

Metadata-only

Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT

Cesaro, Simone Crocchiolo, Roberto Tridello, Gloria

The role of donor CMV serostatus in the setting of non T-cell depleted haplo-HSCT with post-transplant cyclophosphamide (PT-Cy) has not been specifically addressed so far. Here we analyzed the impact of the donor CMV serological status on the outcome of 983 CMV seropositive (CMV+), acute leukemia patients receiving a first, non T-cell depleted...

Uploaded on: April 14, 2023

DELIA , Mario

Recent uploads